HOCPY
Price
$110.27
Change
-$0.50 (-0.45%)
Updated
Apr 2 closing price
Capitalization
41.52B
33 days until earnings call
TRUMY
Price
$18.50
Change
-$0.10 (-0.54%)
Updated
Apr 2 closing price
Capitalization
24.6B
33 days until earnings call
Ad is loading...

HOCPY vs TRUMY

Header iconHOCPY vs TRUMY Comparison
Open Charts HOCPY vs TRUMYBanner chart's image
Hoya
Price$110.27
Change-$0.50 (-0.45%)
Volume$48.33K
Capitalization41.52B
Terumo
Price$18.50
Change-$0.10 (-0.54%)
Volume$688.03K
Capitalization24.6B
HOCPY vs TRUMY Comparison Chart
Loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOCPY vs. TRUMY commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOCPY is a Hold and TRUMY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (HOCPY: $110.27 vs. TRUMY: $18.50)
Brand notoriety: HOCPY and TRUMY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HOCPY: 165% vs. TRUMY: 409%
Market capitalization -- HOCPY: $41.52B vs. TRUMY: $24.6B
HOCPY [@Medical Specialties] is valued at $41.52B. TRUMY’s [@Medical Specialties] market capitalization is $24.6B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOCPY’s FA Score shows that 0 FA rating(s) are green whileTRUMY’s FA Score has 1 green FA rating(s).

  • HOCPY’s FA Score: 0 green, 5 red.
  • TRUMY’s FA Score: 1 green, 4 red.
According to our system of comparison, TRUMY is a better buy in the long-term than HOCPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOCPY’s TA Score shows that 4 TA indicator(s) are bullish while TRUMY’s TA Score has 5 bullish TA indicator(s).

  • HOCPY’s TA Score: 4 bullish, 4 bearish.
  • TRUMY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both HOCPY and TRUMY are a good buy in the short-term.

Price Growth

HOCPY (@Medical Specialties) experienced а -5.67% price change this week, while TRUMY (@Medical Specialties) price change was -0.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.32%. For the same industry, the average monthly price growth was +1.69%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

HOCPY is expected to report earnings on May 07, 2025.

TRUMY is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Medical Specialties (-4.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOCPY($41.5B) has a higher market cap than TRUMY($24.6B). TRUMY has higher P/E ratio than HOCPY: TRUMY (38.46) vs HOCPY (34.84). TRUMY YTD gains are higher at: -7.795 vs. HOCPY (-11.076). HOCPY has higher annual earnings (EBITDA): 267B vs. TRUMY (185B). HOCPY has more cash in the bank: 426B vs. TRUMY (163B). HOCPY has less debt than TRUMY: HOCPY (24.6B) vs TRUMY (232B). TRUMY has higher revenues than HOCPY: TRUMY (798B) vs HOCPY (734B).
HOCPYTRUMYHOCPY / TRUMY
Capitalization41.5B24.6B169%
EBITDA267B185B144%
Gain YTD-11.076-7.795142%
P/E Ratio34.8438.4691%
Revenue734B798B92%
Total Cash426B163B261%
Total Debt24.6B232B11%
FUNDAMENTALS RATINGS
HOCPY vs TRUMY: Fundamental Ratings
HOCPY
TRUMY
OUTLOOK RATING
1..100
7451
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
7372
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7552
P/E GROWTH RATING
1..100
7996
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRUMY's Valuation (18) in the null industry is in the same range as HOCPY (48). This means that TRUMY’s stock grew similarly to HOCPY’s over the last 12 months.

TRUMY's Profit vs Risk Rating (72) in the null industry is in the same range as HOCPY (73). This means that TRUMY’s stock grew similarly to HOCPY’s over the last 12 months.

TRUMY's SMR Rating (100) in the null industry is in the same range as HOCPY (100). This means that TRUMY’s stock grew similarly to HOCPY’s over the last 12 months.

TRUMY's Price Growth Rating (52) in the null industry is in the same range as HOCPY (75). This means that TRUMY’s stock grew similarly to HOCPY’s over the last 12 months.

HOCPY's P/E Growth Rating (79) in the null industry is in the same range as TRUMY (96). This means that HOCPY’s stock grew similarly to TRUMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOCPYTRUMY
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 18 days ago
67%
Bullish Trend 18 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Ad is loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGPSX71.66N/A
N/A
ProFunds Mid Cap Growth Svc
SCPAX10.22N/A
N/A
SEI Large Cap Disciplined Eq A (SIIT)
FSSZX34.76N/A
N/A
Fidelity Advisor Stock Selector Sm Cp Z
FGNCX11.94N/A
N/A
Nuveen Global Infrastructure C
MGTCX7.90N/A
N/A
Transamerica Mid Cap Growth C

HOCPY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOCPY has been loosely correlated with TRUMY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HOCPY jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOCPY
1D Price
Change %
HOCPY100%
-0.45%
TRUMY - HOCPY
47%
Loosely correlated
-0.54%
SSMXY - HOCPY
42%
Loosely correlated
-2.44%
ISRG - HOCPY
38%
Loosely correlated
+2.15%
OLYMY - HOCPY
36%
Loosely correlated
-0.08%
SMTI - HOCPY
34%
Loosely correlated
-0.99%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-2.81%
HOCPY - TRUMY
51%
Loosely correlated
-4.82%
SSMXY - TRUMY
45%
Loosely correlated
-1.63%
SMTI - TRUMY
43%
Loosely correlated
-1.86%
OLYMY - TRUMY
40%
Loosely correlated
-2.90%
AZTA - TRUMY
39%
Loosely correlated
-11.61%
More